TGFB1 and Hepatic fibrosis: Moreover, the higher dose of NIC (15 mg/kg) further improved these parameters, reducing TGF-β1 levels by 70.45%, HYP content by 67.04%, and COL1α1 expression by 50.03% compared to the TAA–induced liver fibrosis group (Fig. 1A–C).